Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

A

AKTX

Akari Therapeutics Plc ADR

7.85

Aug 21 • 3:59 PM ET +0.06 (0.77%)

7.69

Aftermarket • 7:30 PM ET -0.16 (-2.04%)

Healthcare Biotechnology USA Nano NASD

Peers: IKT NBP NERV NVCT ALXO BCYC CGEN FATE FHTX CDXS

Scroll to Statements

Index	-
Market Cap	13.74M
Enterprise Value	6.68M
Income	-30.90M
Sales	0.00M
Book/sh	10.62
Cash/sh	4.43
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	6
IPO	May 07, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.74
P/C	1.77
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	0.60
Current Ratio	0.60
Debt/Eq	0.04
LT Debt/Eq	0.00
Option/Short	Yes / Yes

EPS (ttm)	-17.25
EPS next Y	-2.33
EPS next Q	-2.09
EPS this Y	48.40%
EPS next Y	78.16%
EPS next 5Y	46.65%
EPS past 3/5Y	- -
Sales past 3/5Y	- -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	1.39%
Sales Q/Q	-
Earnings	Aug 13 AMC
EPS/Sales Surpr.	100.00% -

Insider Own	0.40%
Insider Trans	0.00%
Inst Own	8.61%
Inst Trans	235.73%
ROA	-69.02%
ROE	-139.80%
ROIC	-166.16%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	1.51%
SMA50	-22.03%
SMA200	-26.17%
Trades

Shs Outstand	1.75M
Shs Float	1.74M
Short Float	1.57%
Short Ratio	0.03
Short Interest	0.03M
52W High	49.60 -84.17%
52W Low	3.02 160.36%
Volatility	8.27% 9.93%
ATR (14)	0.96
RSI (14)	44.13
Beta	1.39
Rel Volume	0.01
Avg Volume	788.13K
Volume	10,988

Perf Week	4.11%
Perf Month	-15.59%
Perf Quarter	52.72%
Perf Half Y	-17.05%
Perf YTD	-32.09%
Perf Year	-78.78%
Perf 3Y	-94.47%
Perf 5Y	-99.39%
Perf 10Y	-99.91%
Recom	1.00
Target Price	28.50
Prev Close	7.79
Price	7.85
Change %	0.77%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)